p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics
Background: The KRAS exon 2 p. G12C mutation in patients with lung adenocarcinoma has been increasing in relevance due to the development and effectiveness of new treatment medications. Studies around different populations indicate that regional variability between ethnic groups and ancestries could...
Enregistré dans:
Auteurs principaux: | Alejandro Ruiz-Patiño, July Rodríguez, Andrés F. Cardona, Jenny Ávila, Pilar Archila, Hernán Carranza, Carlos Vargas, Jorge Otero, Oscar Arrieta, Lucia Zatarain-Barrón, Carolina Sotelo, Camila Ordoñez, Juan Esteban García-Robledo, Leonardo Rojas, Maritza Bermúdez, Tatiana Gámez, Diana Mayorga, Luis Corrales, Claudio Martín, Gonzalo Recondo, Luis Mas, Suraj Samtani, Luisa Ricaurte, Umberto Malapelle, Alessandro Russo, Feliciano Barrón, Nicolas Santoyo, Christian Rolfo, Rafael Rosell |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2022
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dea50884219f4b58aada2eb1e72a93c5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CRISPR and KRAS: a match yet to be made
par: Guzide Bender, et autres
Publié: (2021) -
KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
par: Olga I. Brovkina, et autres
Publié: (2021) -
Oncogenic KRAS: Signaling and Drug Resistance
par: Hyeon Jin Kim, et autres
Publié: (2021) -
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
par: Gongmin Zhu, et autres
Publié: (2021) -
Comprehensive review of fetal adenocarcinoma of the lung
par: Ricaurte LM, et autres
Publié: (2018)